Institutional Ownership
Enlivex Therapeutics Ltd
CUSIP M4130Y106COMQ1 2026
13D / 13G Filings
5
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
35
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
5 filings · latest Aug 14, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Aug 14, 2025 | Armistice Capital, LLC | 13G/A | 5.0% | 209.3K | SEC |
| 2 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 7.5% | 1.78M | SEC |
| 3 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 9.8% | 2.21M | SEC |
| 4 | Nov 14, 2024 | Armistice Capital, LLC | 13G | 10.0% | 2.18M | SEC |
| 5 | Feb 14, 2020 | Nussbaum Ran | 13G/A | 0.5% | 46.8K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Diametric Capital, LP | 1.48M | $1.38M |
| 2 | Ark Investment Management LLC | 628.3K | $584.4K |
| 3 | Prelude Capital Management, LLC | 225.7K | $210.0K |
| 4 | Two Sigma Investments, LP | 146.4K | $136.2K |
| 5 | Ubs Group AG | 138.3K | $128.6K |
| 6 | Bank Of America Corp /De/ | 130.4K | $121.3K |
| 7 | Renaissance Technologies LLC | 128.2K | $119.2K |
| 8 | Jpmorgan Chase & Co | 125.9K | $113.4K |
| 9 | Goldman Sachs Group Inc | 102.1K | $95.0K |
| 10 | Xtx Topco Ltd | 100.4K | $93.3K |